X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Coromandel Intern. with MANGALORE CHEM. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

COROMANDEL INTERN. vs MANGALORE CHEM. - Comparison Results

COROMANDEL INTERN.    Change

Coromandel International Limited (CIL) is in the business segments of Fertilisers, Speciality Nutrients, Crop Protection and Retail. Coromandel manufactures a wide range of fertilisers and markets around 2.9 million tons making it a leader in its add... More

MANGALORE CHEM. 
   Change

Mangalore Chemicals and Fertlizers (MCF) is a member of the UB Group headed by Mr. Vijay Mallaya. MCF is a manufacturer of fertilizers (both nitrogenous and phosphatic). Its main products, Urea & Di-Ammonium Phosphate (DAP), are marketed under the tr... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    COROMANDEL INTERN. MANGALORE CHEM. COROMANDEL INTERN./
MANGALORE CHEM.
 
P/E (TTM) x 16.9 9.9 170.6% View Chart
P/BV x 4.0 1.4 280.8% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 COROMANDEL INTERN.   MANGALORE CHEM.
EQUITY SHARE DATA
    COROMANDEL INTERN.
Mar-17
MANGALORE CHEM.
Mar-16
COROMANDEL INTERN./
MANGALORE CHEM.
5-Yr Chart
Click to enlarge
High Rs35891 396.0%   
Low Rs18835 532.6%   
Sales per share (Unadj.) Rs343.9253.1 135.9%  
Earnings per share (Unadj.) Rs16.4-20.3 -80.7%  
Cash flow per share (Unadj.) Rs19.8-17.6 -112.4%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %1.80-  
Book value per share (Unadj.) Rs99.135.4 279.9%  
Shares outstanding (eoy) m291.67118.52 246.1%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.80.2 319.7%   
Avg P/E ratio x16.7-3.1 -538.1%  
P/CF ratio (eoy) x13.8-3.6 -386.4%  
Price / Book Value ratio x2.81.8 155.2%  
Dividend payout %30.60-   
Avg Mkt Cap Rs m79,6847,455 1,068.9%   
No. of employees `0004.3NA-   
Total wages/salary Rs m3,108704 441.6%   
Avg. sales/employee Rs Th23,278.6NM-  
Avg. wages/employee Rs Th721.4NM-  
Avg. net profit/employee Rs Th1,106.9NM-  
INCOME DATA
Net Sales Rs m100,30830,000 334.4%  
Other income Rs m54862 884.2%   
Total revenues Rs m100,85630,062 335.5%   
Gross profit Rs m9,8271,068 919.9%  
Depreciation Rs m1,007313 322.1%   
Interest Rs m2,2381,121 199.7%   
Profit before tax Rs m7,130-303 -2,350.8%   
Minority Interest Rs m-70-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-2,167 0.0%   
Tax Rs m2,353-69 -3,414.7%   
Profit after tax Rs m4,770-2,401 -198.6%  
Gross profit margin %9.83.6 275.1%  
Effective tax rate %33.022.7 145.3%   
Net profit margin %4.8-8.0 -59.4%  
BALANCE SHEET DATA
Current assets Rs m68,36718,031 379.2%   
Current liabilities Rs m55,79118,571 300.4%   
Net working cap to sales %12.5-1.8 -696.1%  
Current ratio x1.21.0 126.2%  
Inventory Days Days6329 215.1%  
Debtors Days Days5959 99.7%  
Net fixed assets Rs m13,4956,510 207.3%   
Share capital Rs m2921,186 24.6%   
"Free" reserves Rs m28,6162,250 1,272.0%   
Net worth Rs m28,9084,196 688.9%   
Long term debt Rs m01,361 0.0%   
Total assets Rs m86,45025,134 344.0%  
Interest coverage x4.20.7 573.9%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.21.2 97.2%   
Return on assets %8.1-5.1 -159.1%  
Return on equity %16.5-57.2 -28.8%  
Return on capital %32.4-24.3 -133.4%  
Exports to sales %00.1 0.0%   
Imports to sales %030.7 0.0%   
Exports (fob) Rs mNA27 0.0%   
Imports (cif) Rs mNA9,211 0.0%   
Fx inflow Rs m5,27127 19,238.0%   
Fx outflow Rs m52,8469,273 569.9%   
Net fx Rs m-47,575-9,246 514.5%   
CASH FLOW
From Operations Rs m9,152-1,374 -666.3%  
From Investments Rs m-786-501 156.9%  
From Financial Activity Rs m-8,6441,779 -486.0%  
Net Cashflow Rs m-278-96 288.7%  

Share Holding

Indian Promoters % 63.2 38.4 164.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.8 1.4 414.3%  
FIIs % 7.0 0.4 1,750.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 24.0 59.8 40.1%  
Shareholders   46,421 58,058 80.0%  
Pledged promoter(s) holding % 0.0 10.4 0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare COROMANDEL INTERN. With:   DEEPAK FERTILISERS  GUJ.NARMADA  CHAMBAL FERTILISERS  GUJARAT STATE FERTILIZERS  TATA CHEMICALS  



Today's Market

Sensex Opens Lower; Realty & Auto Stocks Top Losers(09:30 am)

Asian shares eased in holiday-thinned trading on Monday and the safe haven yen gained as China canceled upcoming tariff talks with the United States.

Related Views on News

MANGALORE CHEM. Announces Quarterly Results (1QFY19); Net Profit Up 22.7% (Quarterly Result Update)

Aug 1, 2018 | Updated on Aug 1, 2018

For the quarter ended June 2018, MANGALORE CHEM. has posted a net profit of Rs 39 m (up 22.7% YoY). Sales on the other hand came in at Rs 7 bn (up 13.1% YoY). Read on for a complete analysis of MANGALORE CHEM.'s quarterly results.

COROMANDEL INTERN. Announces Quarterly Results (1QFY19); Net Profit Up 19.1% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, COROMANDEL INTERN. has posted a net profit of Rs 905 m (up 19.1% YoY). Sales on the other hand came in at Rs 25 bn (up 11.0% YoY). Read on for a complete analysis of COROMANDEL INTERN.'s quarterly results.

MANGALORE CHEM. Announces Quarterly Results (4QFY18); Net Profit Up 333.2% (Quarterly Result Update)

Jun 4, 2018 | Updated on Jun 4, 2018

For the quarter ended March 2018, MANGALORE CHEM. has posted a net profit of Rs 203 m (up 333.2% YoY). Sales on the other hand came in at Rs 6 bn (up 16.3% YoY). Read on for a complete analysis of MANGALORE CHEM.'s quarterly results.

Tata Chemicals: Lower Finance Costs Boost Profits (Quarterly Results Update - Detailed)

Jun 2, 2017

Tata Chemicals registers 54.2% YoY rise in net profits during fourth quarter of FY17 on the back of lower finance costs and rise in other income.

Tata Chemicals: Urea division dampens performance (Quarterly Results Update - Detailed)

Nov 18, 2016

Tata Chemicals has reported consolidated topline fall of 17% YoY while the bottomline has fallen 5% YoY

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

COROMANDEL INTERN. SHARE PRICE


Sep 24, 2018 09:47 AM

TRACK COROMANDEL INTERN.

  • Track your investment in COROMANDEL INTERN. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON COROMANDEL INTERN.

COROMANDEL INTERN. - NATIONAL FERT. COMPARISON

COMPARE COROMANDEL INTERN. WITH

MARKET STATS